Table 3.
Comparative studies of immunomodulatory activities of N. sativa Linn and Thymoquinone.
| Activity | N. sativa | Thymoquinone | Reference |
|---|---|---|---|
| Cellular immunity | Improvement of the proliferative capability of T lymphocytes and splenocytes | Improvement of number of circulating and thymus-homing CD4+ and CD8+ T lymphocytes |
(Badr et al., 2011; Majdalawieh et al., 2010; Swamy and Tan, 2000) |
| Increase IL-3 secretion from PBMCs | Increase IL-2 serum level | (Badr et al., 2011; Haq et al., 1995) | |
| Elevation and suppression of IL-8 secretion from PWM-activated and un-stimulated lymphocytes | Inhibition of cytokine secretion, (IL-10, IL-12, TNFα) and DC maturation survival | (Haq et al., 1999; Xuan et al., 2010) | |
| Enhanced CD4 + T cell count acts as therapeutic role against HIV infection | Suppression of IL-13 and IL-5 release by mast cells | (El Gazzar, 2007; Onifade et al., 2013) | |
| Stimulation of CD4 + T lymphocytes | Increase total leukocyte count, chemokine expression, phagocytic action, chemotaxis | (Onifade et al., 2013; Salem and Hossain, 2000) | |
| Increase peripheral lymphocyte and monocyte counts | Inhibition of DC survival, maturation, and cytokine secretion (IL-10, IL-12, TNFα) | (Fararh et al., 2004; Islam et al., 2004; Xuan et al., 2010) | |
| Humoral immunity | Decrease serum IgA, IgM levels. | Increase total immunoglobulin particularly IgGs levels as well as antibody Hemagglutination | (Ebaid et al., 2011; Mohany et al., 2012; Sapmaz et al., 2016) |